Natera, Inc..
NTRA.US | Other human health activities
Natera, Inc. is a genetic testing company focused on non-invasive methods to analyze DNA. They primarily offer molecular testing services for reproductive health, oncology, and organ health. Their reproductive health offerings include non-invasive prenatal testing (NIPT) to detect chromosomal abnorm...Show More
Better Health for All
-10
Natera's core business, genetic testing for reproductive health, oncology, and organ health, delivers revolutionary health benefits by enabling early detection, personalized treatment, and improved outcomes for serious conditions.
1
The company's tests are validated by over 350 peer-reviewed publications and have processed over 12 million tests.
2
There is no evidence of revenue from products with negative health outcomes. Natera offers a financial assistance program reducing test costs to $149 or less for eligible patients and interest-free payment plans for up to 12 months.
3
However, over 60% of patients have no out-of-pocket cost with insurance, and prompt-pay cash prices are typically $249 or $349.
4
The company targets individuals with a family history of cancer and offers a no-cost renal genetic testing program for eligible patients of African ancestry, who are 4 times more likely to develop kidney failure.
5
Natera provides genetic education through NEVA and webinars for healthcare providers.
6
The company is committed to protecting personal health information, processing it in accordance with HIPAA, CLIA, and GDPR, and has a policy against distributing identifiable patient data.
7
Natera is launching the TEODOR trial to optimize breast cancer treatment and has completed enrollment in the ACES-EMB trial for heart transplantation, with trials monitored by ethics committees and regulatory authorities.
8
Fair Money & Economic Opportunity
-80
Natera faces multiple class-action lawsuits and regulatory inquiries regarding its billing practices.
1
Patients are often quoted a cash price of $249 but later receive bills for thousands of dollars, sometimes as high as $8,000, for tests like microdeletion screenings which are added without clear consent.
2
This represents charges more than 10x the quoted price. The company settled with the Department of Justice for $11 million in 2018 for improper billing and paid an $8.25 million settlement for misrepresenting test reliability.
3
Natera regularly withholds detailed invoices from customers and refuses to send bills reflecting cash payments.
4
The company has never generated a profit, posting a $468.2 million loss from operations in 2021 and an accumulated deficit of $1.4 billion, indicating no profit available for community reinvestment.
5
Patients and practitioners are often unaware of separate billing for microdeletion screens, suggesting a lack of product simplicity in billing.
6
Fair Pay & Worker Respect
0
No quantitative data relevant to Natera, Inc. or the 'Fair Pay & Worker Respect' value was found in the provided articles.
1
The articles explicitly state that they focus on employee reviews of Abacus Settlements, a different company, and do not contain any information about Natera or metrics related to the requested key performance indicators.
2
Fair Trade & Ethical Sourcing
0
No evidence available to assess Natera, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No relevant data was found in the provided articles to assess Natera, Inc. against the 'Honest & Fair Business' ethical value.
1
explicitly stated a lack of relevant information, and was inaccessible due to insufficient data.
2
Kind to Animals
0
No specific, concrete evidence was found in the provided articles to assess Natera, Inc. against any of the 'Kind to Animals' KPIs. The articles primarily focus on the company's genetic testing services,
1
general environmental sustainability,
2
and compliance with environmental regulations,
3
without detailing any animal-related operations, testing, sourcing, or policy engagement relevant to animal welfare.
4
No War, No Weapons
0
No direct evidence was found linking Natera, Inc., a genetic testing company, to arms manufacturing, military contracts, dual-use technologies, or any activities related to war or weapons. The articles primarily discuss healthcare contracts
1
,
2
and general sustainability
3
, or are irrelevant to the company's operations in the context of this value
4
,
5
,
6
.
Planet-Friendly Business
-60
Natera reported total Scope 1, 2, and 3 emissions of 113,327 tCO₂e in 2022.
1
While this is a low absolute value, the company has not provided evidence of an annual decline percentage for total emissions that meets the thresholds for positive scores. The company uses 0% renewable energy.
2
Natera has not mentioned specific SBTi-aligned targets for its own operations.
3
The company achieved a 55.6% waste diversion rate in 2022 for its Austin and San Carlos sites, with a goal of 80% diversion.
4
Natera reported no environmental compliance violations.
5
The company aligns with TCFD recommendations, focusing on governance, strategy, risk management, and metrics & targets.
6
Climate scenario analysis is conducted for short, medium, and long-term horizons, identifying site-level and operational climate-related risks.
7
Natera reduced kit weight by 8.8% (90,500 pounds of material removed) and achieved a ~31% reduction in kit waste since 2021.
8
For its supply chain, 14% of top 100 suppliers have net-zero goals, 8% have renewable energy goals, 21% have Scope 1&2 reduction initiatives, 10% use CDP reporting, 7% have science-based targets, and 17% disclose Scope 3 emissions.
9
Respect for Cultures & Communities
0
No specific, concrete data points were found in the provided articles that directly address any of the KPIs for 'Respect for Cultures & Communities'. The articles discuss general ESG goals
1
, employee volunteer hours
2
, and patient privacy
3
, but do not provide information on formal partnerships with community groups, revenue reinvested locally, cultural incidents, cultural impact assessments, local employment ratios, community grievance mechanisms, FPIC processes, community governance inclusion, cultural preservation investment, local procurement, indigenous suppliers, cultural site protection, social license, charitable giving to cultural organizations, community fund allocation, language inclusivity, cultural incident response, or cultural sensitivity training completion.
4
Safe & Smart Tech
10
Natera operates ISO 13485-certified, CAP-accredited, and CLIA-certified laboratories.
1
Its security program meets SOC 2 Type II and PCI-DSS standards, certified by an independent firm, and aligns with the NIST Cybersecurity Framework.
2
All Natera sites use secure certificates and TLS for encrypted transmission, and the company uses NIST compliant encryption.
3
Natera states it maintains privacy and security of Protected Health Information (PHI) using technical, physical, and administrative safeguards, and there are no documented incidents of unauthorized data use.
4
Users can review, correct, update, or delete inaccuracies in their information, request disposal of collected biologic material, and opt-out of research and development.
5
Natera adheres to federal, state, and international privacy laws, including HIPAA, CCPA, and CPRA.
6
Zero Waste & Sustainable Products
-30
Natera achieved a 31.2% reduction in single-use plastic consumption.
1
The company has implemented advanced recycling systems in 7 research laboratories, leading to a 26.8% improvement in waste reduction and recycling protocols across these facilities.
2
In 2023, Natera reported a 16.9% reduction in laboratory waste.
3
Since 2021, over 1 million pounds of material have been eliminated from test kits.
4
Natera holds an ISO 14001 environmental management certification.
5
The company has set a target to reduce its non-biohazardous waste footprint per test kit by 25% by 2025 and aims for an 80% non-biohazardous waste diversion rate for its Austin and San Carlos facilities by 2025.
6